Individualized immunosuppression in transplant patients: potential role of pharmacogenetics
Hamid Abboudi, Iain AM MacPheeDivision of Clinical Sciences, Renal Medicine, St George's, University of London, London, UKAbstract: The immunosuppressive drugs used to prevent the rejection of transplanted organs have a narrow therapeutic index. Under treatment results in episodes of rej...
Main Authors: | Abboudi H, MacPhee IA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-06-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Online Access: | http://www.dovepress.com/individualized-immunosuppression-in-transplant-patients-potential-role-a10152 |
Similar Items
-
Patient involvement in selection of immunosuppressive regimen following transplantation
by: Popoola J, et al.
Published: (2014-12-01) -
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
by: Mysore K. Phanish, et al.
Published: (2020-03-01) -
Expression and localisation of proteins with a proposed role in mechanosensing in cells of the osteoblast lineage
by: MacPhee, Jeny
Published: (2004) -
Orthognathic surgery in the immunosuppressed post-organ transplant individual
by: Ian Jenkyn, et al.
Published: (2021-04-01) -
THE INDIVIDUAL TAILORING OF IMMUNOSUPPRESSIVE THERAPY AFTER HEART TRANSPLANTATION
by: N. N. Koloskova, et al.
Published: (2018-04-01)